Filed before 2025Filed 1 March 2016
Mersana Therapeutics, Inc. has sold $10.1M so far
Mersana Therapeutics, Inc., a biotech company based in Cambridge, MA, has sold $10.1M so far in its equity round, according to a filing dated 1 March 2016.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 1 March 2016
- First filed
- 3 March 2015
- Round
- Equity round (amended filing)
- Amount sold
- $10.1M
- Offering size
- $35.5M
- Investors so far
- 10
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 69% of the 1,506 tracked raises with an amount filed in 2016, and than 62% of the 120 in biotech.
Mersana Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 24 Jun 2016 | New filing | $33.1M | Another raise |
| 1 Mar 2016 | Amended filing | $10.1M | This raise |
More with New Enterprise Associates on the board
- Databricks, Inc.$5B
- Qualified Health PBC$10M
- Play Versus Inc.$3.98M
- FOMO Labs Inc.$67.3M
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.